| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.012 | 0.9 |